$Inotek Pharmaceuticals Corporation(ITEK)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-12-22 AccNo: 0001193125-17-377734 Size: 25 KB 网页链接
$Inotek Pharmaceuticals Corporation(ITEK)$ 8-K - Current report Filed: 2017-12-22 AccNo: 0001193125-17-377733 Size: 25 KBItem 8.01: Other Events 网页链接
$Inotek Pharmaceuticals Corporation(ITEK)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2017-12-04 AccNo: 0001193125-17-360226 Size: 8 MB 网页链接
$Inotek Pharmaceuticals Corporation(ITEK)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2017-11-20 AccNo: 0001193125-17-348190 Size: 8 MB 网页链接
$Inotek Pharmaceuticals Corporation(ITEK)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-08 AccNo: 0001564590-17-022495 Size: 7 MB 网页链接
$Inotek Pharmaceuticals Corporation(ITEK)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-10-26 AccNo: 0000902664-17-004092 Size: 91 KB 网页链接
$Inotek Pharmaceuticals Corporation(ITEK)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-10-12 AccNo: 0001193125-17-308940 Size: 49 KB 网页链接
$Inotek Pharmaceuticals Corporation(ITEK)$ 8-K - Current report Filed: 2017-10-12 AccNo: 0001193125-17-308939 Size: 49 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Inotek Pharmaceuticals Corporation(ITEK)$ PREM14A - Preliminary proxy statements relating to merger or acquisition Filed: 2017-10-12 AccNo: 0001193125-17-308897 Size: 8 MB 网页链接
$Inotek Pharmaceuticals Corporation(ITEK)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-10-06 AccNo: 0001493152-17-011384 Size: 126 KB 网页链接